Loading...

Enveric Biosciences, Inc.

ENVB•NASDAQ
Healthcare
Biotechnology
$3.37
$-0.28(-7.67%)
U.S. Market opens in 12h 30m

Enveric Biosciences, Inc. (ENVB) Stock Overview

Explore Enveric Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2M
P/E Ratio-0.42
EPS (TTM)$-36.24
ROE-2.55%
Fundamental Analysis

AI Price Forecasts

1 Month$2.42
3 Months$1.13
1 Year Target$0.00

ENVB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Enveric Biosciences, Inc. (ENVB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.07, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.42 and a market capitalization of 2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.67%
5-Day Change
71.94%
1-Month Change
65.20%
3-Month Change
-19.18%
6-Month Change
-58.60%
Year-to-Date (YTD) Change
-7.16%
1-Year Change
-76.40%
3-Year Change
-98.96%
5-Year Change
-99.98%
All-Time (Max) Change
-100.00%

Contact Information

https://www.enveric.com
239 302 1707
4851 Tamiami Trail North, Naples, FL, 34103

Company Facts

5 Employees
IPO DateMay 4, 2015
CountryUS
Actively Trading

Frequently Asked Questions